2m 2m 2m 2m 2m 2m 2m
Sang Therap (SGMO)
OTC
$0.15-$0.06 (-30.37%)
Price as of May 04, 2026 7:59 PM EDT- $47.6MMarket Cap
- -57.22%1-Year Change
- BiotechnologyIndustry
Sang Therap (SGMO)
$0.15-$0.06 (-30.37%)
SGMO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.21 | ||
Change | +$0.003 (+1.30%) | ||
Open | $0.22 | ||
High | $0.23 | ||
Low | $0.19 | ||
Previous Close | $0.21 | ||
Volume | 3,358,084 | ||
30-Day Average Volume | 12,466,146 | ||
1-Week Change | 15.61% | ||
1-Month Change | 58.52% | ||
1-Year Change | -57.22% | ||
3-Year Change | -81.39% | ||
5-Year Change | -98.03% | ||
Fundamentals | |||
Shares Outstanding | 414.3M | ||
Total Assets | $59.7M | ||
Market Cap | $47.6M | ||
Enterprise Value | $26.7M | ||
Period: QTR TTM FY | |||
Revenue | $8.8M | ||
Net Income | -$37.4M | ||
Free Cash Flow | -$24.4M | ||
EBIT | -$38.0M | ||
EBITDA | -$37.0M | ||
Net Working Capital | -$6.6M | ||
EPS | -$0.11 | ||
Enterprise Value/EBITDA | -1 | ||
Enterprise Value/Revenue | 3 | ||
P/B | -3 | ||
P/E | -1 | ||
PEG | 1 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||